Co-Irbesartan Spirig HC 150/12.5 mg

Co-Irbesartan Spirig HC 150/12.5 mg is a medicine authorised by Swissmedic under authorisation number 62743. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 March 2013 and the authorisation is valid without a time limit. ATC code C09DA04 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 62743
  • ATC C09DA04
  • Synthetic medicines
Authorisation data
Authorisation number62743
NameCo-Irbesartan Spirig HC 150/12.5 mg
Full nameCo-Irbesartan Spirig HC 150/12.5 mg, Filmtabletten
Authorisation holderSpirig HealthCare AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09DA04
First authorisation05 March 2013
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Co-Irbesartan Spirig HC 150/12.5 mg, FilmtablettenB05 March 2013
2Co-Irbesartan Spirig HC 300/12.5 mg, FilmtablettenB05 March 2013
3Co-Irbesartan Spirig HC 300/25 mg, FilmtabletteB05 March 2013

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)C09DA0402.07.2.B
298Tablette(n)C09DA0402.07.2.B
328Tablette(n)C09DA0402.07.2.B
498Tablette(n)C09DA0402.07.2.B
528Tablette(n)C09DA0402.07.2.B
698Tablette(n)C09DA0402.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Co-Irbesartan Spirig HC 150/12.5 mg authorised in Switzerland?

Yes. Co-Irbesartan Spirig HC 150/12.5 mg is authorised by Swissmedic under authorisation number 62743, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Co-Irbesartan Spirig HC 150/12.5 mg have?

Co-Irbesartan Spirig HC 150/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Co-Irbesartan Spirig HC 150/12.5 mg?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com